New York A 8932: Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication

Status: REFERRED TO HEALTH (as of 2020-01-08)

State: New York · Session: 2019-2020 · Bill: A 8932

Sponsors: BARCLAY

View New York A 8932 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.